0
Skip to Content
GripRoom
Pop Culture Food
Meal Prep
High Protein/Low Calorie
Healthy Fast Food
Healthy Living
Everything
GripRoom
Pop Culture Food
Meal Prep
High Protein/Low Calorie
Healthy Fast Food
Healthy Living
Everything
Pop Culture Food
Meal Prep
High Protein/Low Calorie
Healthy Fast Food
Healthy Living
Everything
Iovance Biotherapeutics Short Squeeze Potential ($20)
Jim Rogan 2/20/24 Jim Rogan 2/20/24

Iovance Biotherapeutics Short Squeeze Potential ($20)

Read More
How does CRISPR work, step by step?
Jim Rogan 1/4/24 Jim Rogan 1/4/24

How does CRISPR work, step by step?

Read More
Viking Therapeutics (VKTX) Could Squeeze to $40
Mark Armstrong 12/13/23 Mark Armstrong 12/13/23

Viking Therapeutics (VKTX) Could Squeeze to $40

Read More
Why Viking Therapeutics (VKTX) is a Buy Going into 2024
Sam Chang 12/12/23 Sam Chang 12/12/23

Why Viking Therapeutics (VKTX) is a Buy Going into 2024

Read More
Gilead and Assembly Strike a Huge Deal Amidst Biotech Bear Market
Luca Marino 10/17/23 Luca Marino 10/17/23

Gilead and Assembly Strike a Huge Deal Amidst Biotech Bear Market

Read More
Gritstone Bio Unveils Game-Changing COVID-19 Vaccine Results
Mark Armstrong 10/11/23 Mark Armstrong 10/11/23

Gritstone Bio Unveils Game-Changing COVID-19 Vaccine Results

Read More
Gritstone Bio and the Calm Before the Storm
David Stone 10/7/23 David Stone 10/7/23

Gritstone Bio and the Calm Before the Storm

Read More
The Next Moderna? How Gritstone Bio Could Dominate the Vaccine Industry
David Stone 9/28/23 David Stone 9/28/23

The Next Moderna? How Gritstone Bio Could Dominate the Vaccine Industry

Read More
10 Reasons to Invest in Moderna: A Biotech Powerhouse
Mark Armstrong 5/15/23 Mark Armstrong 5/15/23

10 Reasons to Invest in Moderna: A Biotech Powerhouse

Read More
BioNTech's Hesitance and Matinas BioPharma's Persistence: A Study in Risk Tolerance
David Stone 5/11/23 David Stone 5/11/23

BioNTech's Hesitance and Matinas BioPharma's Persistence: A Study in Risk Tolerance

Read More
Why It Takes Time for Companies to Share FDA Meeting Outcomes with Investors
Mark Armstrong 5/2/23 Mark Armstrong 5/2/23

Why It Takes Time for Companies to Share FDA Meeting Outcomes with Investors

Read More
Trojan Horse Drug Delivery: The Future of Medicine and Matinas BioPharma's LNC Technology
Isha Tanaka 5/2/23 Isha Tanaka 5/2/23

Trojan Horse Drug Delivery: The Future of Medicine and Matinas BioPharma's LNC Technology

Read More
11 Reasons to Invest in Virios Therapeutics
John Wilson 4/25/23 John Wilson 4/25/23

11 Reasons to Invest in Virios Therapeutics

Read More
Is BioNTech About to Take a Major Stake in Matinas BioPharma?
David Stone 4/24/23 David Stone 4/24/23

Is BioNTech About to Take a Major Stake in Matinas BioPharma?

Read More
The Growing Need for Novel Antifungals
Sarah Martinez 4/21/23 Sarah Martinez 4/21/23

The Growing Need for Novel Antifungals

Read More
Moderna's Cancer Vaccine Shows Promising Results in Melanoma Prevention
Isha Tanaka 4/16/23 Isha Tanaka 4/16/23

Moderna's Cancer Vaccine Shows Promising Results in Melanoma Prevention

Read More
Candida auris: A Growing Health Threat to Hospitalized Patients
Mark Armstrong 4/8/23 Mark Armstrong 4/8/23

Candida auris: A Growing Health Threat to Hospitalized Patients

Read More
The Impact of ChatGPT on the Healthcare Industry
Ella Bianchi 3/21/23 Ella Bianchi 3/21/23

The Impact of ChatGPT on the Healthcare Industry

Read More
Revolutionizing mRNA Therapeutics: The Promise of a Novel Oral Drug Delivery System
David Stone 3/19/23 David Stone 3/19/23

Revolutionizing mRNA Therapeutics: The Promise of a Novel Oral Drug Delivery System

Read More
10 Reasons to Invest in Biotech in 2023
Jim Rogan 2/26/23 Jim Rogan 2/26/23

10 Reasons to Invest in Biotech in 2023

Read More
Older Posts

About GripRoom Privacy Policy

Disclaimer: Nothing on this website is medical, legal, investment, or any other type of serious advice. This website is for entertainment purposes only. Always consult a professional before making an important decision.